AKT1 and lip and oral cavity carcinoma: A previous study showed that GLY restores proper TNF-α levels in human oral cancer cells by acting on nuclear factor kappa-B (NF-κB), protein kinase B (AKT), and extracellular regulated protein kinases (ERK)-dependent pathways [18].